Abstract:Nowadays, although chemotherapy is an established therapy for breast cancer, the molecular mechanisms of chemotherapy resistance in breast cancer remain poorly understood. This study aims to explore the effects of endoplasmic reticulum stress on autophagy, apoptosis, and chemotherapy resistance in human breast cancer cells by regulating PI3K/AKT/mTOR signaling pathway. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was performed to detect the cell viability of six human breast cancer cell lines (MCF-7, ZR-75-30, T47D, MDA-MB-435s, MDA-MB-453, and MDA-MB-231) treated with tunicamycin (5 μM), after which MCF-7 cells were selected for further experiment. Then, MCF-7 cells were divided into the control (without any treatment), tunicamycin (8 μ), BEZ235 (5 μ), and tunicamycin + BEZ235 groups. Cell viability of each group was testified by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Western blotting was applied to determine the expressions of endoplasmic reticulum stress and PI3K/AKT/mTOR pathway–related proteins and autophagy- and apoptosis-related proteins. Monodansylcadaverine and Annexin V–fluorescein isothiocyanate/propidium iodide staining were used for determination of cell autophagy and apoptosis. Furthermore, MCF-7 cells were divided into the control (without any treatment), tunicamycin (5 μM), cisplatin (16 μM), cisplatin (16 μM) + BEZ235 (5 μM), tunicamycin (5 μM) + cisplatin (16 μM), and tunicamycin (5 μM) + cisplatin (16 μM) + BEZ235 groups. Cell viability and apoptosis were also evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and Annexin V–fluorescein isothiocyanate/propidium iodide staining. In MCF-7 cells treated with tunicamycin, cell viability decreased significantly, but PEAK, eIF2, and CHOP were upregulated markedly and p-PI3K, p-AKT, and p-MTOR were downregulated in dose- and time-dependent manners. In the tunicamycin + BEZ235 group, the cell viability was lower and the apoptosis rate was higher than those of the control and monotherapy groups. Compared with the cisplatin group, the tunicamycin + cisplatin group showed a relatively higher growth inhibition rate; the growth inhibition rate substantially increased in the tunicamycin + cisplatin + BEZ235 group than the tunicamycin + cisplatin group. The apoptosis rate was highest in tunicamycin + cisplatin + BEZ235 group, followed by tunicamycin + cisplatin group and then cisplatin group. Our study provide evidence that endoplasmic reticulum stress activated by tunicamycin could promote breast cancer cell autophagy and apoptosis and enhance chemosensitivity of MCF-7 cells by inhibiting the PI3K/AKT/mTOR signaling pathway.

Induction of Autophagy by the MG‑132 Proteasome Inhibitor is Associated with Endoplasmic Reticulum Stress in MCF‑7 Cells.

Inhibition of autophagy promotes cell apoptosis induced by the proteasome inhibitor MG-132 in human esophageal squamous cell carcinoma EC9706 cells

Inhibition of ERα/ERK/P62 cascades induces "autophagic switch" in the estrogen receptor-positive breast cancer cells exposed to gemcitabine.

An Autophagy Inhibitor Enhances the Inhibition of Cell Proliferation Induced by A Proteasome Inhibitor in Mcf-7 Cells

MG132, a Proteasome Inhibitor, Induces Apoptosis in Tumor Cells

Inhibition of Autophagy Induced by Proteasome Inhibition Increases Cell Death in Human SHG-44 Glioma Cells

A Study on the Mechanism of the Inhibition of Bel-7404 Hepatocarcinoma Cell Growth by MG132

The Cytoprotective Role Of Gemcitabine-Induced Autophagy Associated With Apoptosis Inhibition In Triple-Negative Mda-Mb-231 Breast Cancer Cells

Autophagy Inhibitor Sensitizes MCF-7 Breast Cancer Cells to Novel Cyclic Tetrapeptide CTS203-induced Caspase-9-dependent Apoptotic Cell Death.

The Mechanism of Proteasome Inhibitor MG132 Induces Ovarian Carcinoma Cells Autophagic and Apoptotic

Proteasome inhibition induces macrophage apoptosis via mitochondrial dysfunction

Proteasome Inhibitor MG-132 Induces C6 Glioma Cell Apoptosis Via Oxidative Stress

Effects of Proteasome Inhibitor MG132 on Cell Proliferation, Apoptosis, and Cell Cycle in HEC-1B and Ishikawa Cells

Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway

2-Deoxy-d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion

Marsdenia tenacissima extract induces apoptosis and suppresses autophagy through ERK activation in lung cancer cells

MG132-mediated Suppression of the Ubiquitin-proteasome Pathway Enhances the Sensitivity of Endometrial Cancer Cells to Cisplatin

Atg7- and Keap1-dependent autophagy protects breast cancer cell lines against mitoquinone-induced oxidative stress

Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells

In vitro study on activating autophagy pathway of SHG-44 glioma cells by MG-132

Endoplasmic reticulum stress induces autophagy and apoptosis while inhibiting proliferation and drug resistance in multiple myeloma through the PI3K/Akt/mTOR signaling pathway.